Jun
4
di Giancarlo Nicoli
Thursday, 7 June 2012
Provenge Has A Bigger Market Than You Think
http://seekingalpha.com/article/643181-provenge-has-a-bigger-market-than-you-think
Monday, 4 June 2012
Dendreon slide seen coming to an end
http://finance.yahoo.com/news/dendreon-slide-seen-coming-end-151958149.html
A trader sold 3,555 July 6 puts for the bid price of $0.60
Monday, 4 June 2012
Johnson & Johnson’s Prostate Drug Fails Clinical Trial
http://www.minyanville.com/sectors/biotech-pharma/articles/
jnj-johnson-and-johnson-cancer-drugs/6/4/2012/id/41448
Ocyan on ’302′…
http://www.investorvillage.com/smbd.asp?mb=971&mn=439538&pt=msg&mid=11789245
Monday, 4 June 2012
Johnson & Johnson’s Zytiga Data Argue For Sequencing Dendreon’s Provenge First
http://seekingalpha.com/article/634551-
johnson-johnson-s-zytiga-data-argue-for-sequencing-dendreon-s-provenge-first
@ @ @
DNDN website:
http://www.dendreon.com/
Provenge website:
http://provenge.com/
All links are verified and working at date of publication.
Tags:
Dendreon, Dendreon, DNDN, Investimenti, Provenge, ZytigaComments
Leave a Reply
You must be logged in to post a comment.

